Literature DB >> 18519948

Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?

Rob Glynne-Jones1, Suzy Mawdsley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519948     DOI: 10.1200/JCO.2008.18.1651

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Epidermoid cancers of the anal canal: current treatment.

Authors:  Jennifer Blumetti; Amir L Bastawrous
Journal:  Clin Colon Rectal Surg       Date:  2009-05

2.  Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Authors:  Madhur K Garg; Fengmin Zhao; Joseph A Sparano; Joel Palefsky; Richard Whittington; Edith P Mitchell; Mary F Mulcahy; Karin I Armstrong; Nassim H Nabbout; Shalom Kalnicki; Bassel F El-Rayes; Adedayo A Onitilo; Daniel J Moriarty; Thomas J Fitzgerald; Al B Benson
Journal:  J Clin Oncol       Date:  2017-01-09       Impact factor: 44.544

3.  Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma.

Authors:  Maria G Zampino; Elena Magni; Maria C Leonardi; Luigi Santoro; Elena Petazzi; Cristiana Fodor; Giuseppe Petralia; Cristina Trovato; Franco Nolè; Roberto Orecchia
Journal:  BMC Cancer       Date:  2011-02-03       Impact factor: 4.430

4.  CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Zhien Feng; Wei Guo; Chenping Zhang; Qin Xu; Ping Zhang; Jian Sun; Hanguang Zhu; Zhonghe Wang; Jiang Li; Lizhen Wang; Bingshun Wang; Guoxin Ren; Tong Ji; Wenyong Tu; Xihu Yang; Weiliu Qiu; Li Mao; Zhiyuan Zhang; Wantao Chen
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

5.  EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Authors:  A Paliga; R Onerheim; A Gologan; G Chong; A Spatz; T Niazi; A Garant; D Macheto; T Alcindor; T Vuong
Journal:  Br J Cancer       Date:  2012-10-23       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.